3
Case Report Myasthenia Gravis following Low-Osmolality Iodinated Contrast Media Luca Bonanni, Michele Dalla Vestra, Andrea Zancanaro, and Fabio Presotto Department of Internal Medicine, “Dell’Angelo” General Hospital, 11 Paccagnella Street, Mestre, 30171 Venice, Italy Correspondence should be addressed to Luca Bonanni; [email protected] Received 14 October 2014; Accepted 18 November 2014; Published 3 December 2014 Academic Editor: Salah D. Qanadli Copyright © 2014 Luca Bonanni et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We describe the case of 79-year-old man admitted to our general hospital for a 6-week history of progressive dysphagia to solids and liquids associated with weight loss. To reach a diagnosis a total body CT scan with low-osmolality iodinate contrast agent was performed. Two hours later the patient developed an acute respiratory failure requiring orotracheal intubation and mechanical ventilation. e laboratory and neurological tests allow formulating the diagnosis of myasthenia gravis. In literature, other three case reports have associated myasthenic crisis with exposure to low-osmolality contrast media. is suggests being careful in administering low-osmolality contrast media in myasthenic patients. 1. Introduction Myasthenia gravis is oſten underrecognised in the elderly people, partly because symptoms such as dysphagia, fatigue, and slurred speech can have a broad differential diagnosis [1]. CT scan with iodinated contrast media is oſten performed to investigate symptoms connected with this disease (like weight loss). 2. Case Presentation In April 2013, a 79-year-old man was admitted to our gen- eral hospital for a 6-week history of progressive dysphagia to solids and liquids associated with weight loss of 3 kg. He denied any other symptoms. His past medical history included type II diabetes, hypertension, and COPD. He could walk and neurological examination showed no ocular symp- toms or muscle weakness. ere was a mild dehydration, but examination of the cardiovascular and abdominal systems was unremarkable. Investigations showed a mild increase of serum creatinine (1.3 mg/dL). Gastroscopy showed a mild hyperemic duodenitis: for this reason a therapy with Panto- prazole was started. During the stay in our ward he developed a progressive asthenia, leading to inability to walk and to liſt the head to watch the examiner without using his hand. A blood sam- ple was taken to test for acetylcholine-receptor antibodies. e same day, a total body CT scan with low-osmolality iodinate contrast agent (Iohexol, concentration 300 mgI/mL, volume 200 mL) was performed. Two hours later the patient developed an acute respiratory failure requiring orotracheal intubation and mechanical ventilation. In the Intensive Care Unit the weaning of mechanical ventilation was soon ini- tiated and aſter two days the extubation was performed. Aſter the extubation the patient showed complete dysphagia, dysarthria, hypophonia, and proximal muscle hyposthenia. While waiting for the serologic test, pyridostigmine was given: there was a marked improvement in the following 24 hours with a complete neurological recovery. e diagnosis of myasthenia gravis was confirmed by the acetylcholine- receptor antibody test, by the repetitive nerve stimulation, and by the single fibre electromyography. Before the CT scan, the patient never experienced respi- ratory symptoms (dyspnea or orthopnea) and there were no signs of a reexacerbation of COPD (no productive cough; the chest examination was negative for rumors, the respiratory rate was always in the normal range, and the oxygen satura- tion ranged from 94 to 96 in RA). No new drug was added to the therapy with Pantoprazole (that had been administered daily for ten days before the acute respiratory event and it is Hindawi Publishing Corporation Case Reports in Radiology Volume 2014, Article ID 963461, 2 pages http://dx.doi.org/10.1155/2014/963461

Case Report Myasthenia Gravis following Low-Osmolality …downloads.hindawi.com/journals/crira/2014/963461.pdf · Case Report Myasthenia Gravis following Low-Osmolality Iodinated

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Case ReportMyasthenia Gravis following Low-Osmolality IodinatedContrast Media

Luca Bonanni, Michele Dalla Vestra, Andrea Zancanaro, and Fabio Presotto

Department of Internal Medicine, “Dell’Angelo” General Hospital, 11 Paccagnella Street, Mestre, 30171 Venice, Italy

Correspondence should be addressed to Luca Bonanni; [email protected]

Received 14 October 2014; Accepted 18 November 2014; Published 3 December 2014

Academic Editor: Salah D. Qanadli

Copyright © 2014 Luca Bonanni et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

We describe the case of 79-year-old man admitted to our general hospital for a 6-week history of progressive dysphagia to solidsand liquids associated with weight loss. To reach a diagnosis a total body CT scan with low-osmolality iodinate contrast agent wasperformed. Two hours later the patient developed an acute respiratory failure requiring orotracheal intubation and mechanicalventilation. The laboratory and neurological tests allow formulating the diagnosis of myasthenia gravis. In literature, other threecase reports have associated myasthenic crisis with exposure to low-osmolality contrast media. This suggests being careful inadministering low-osmolality contrast media in myasthenic patients.

1. Introduction

Myasthenia gravis is often underrecognised in the elderlypeople, partly because symptoms such as dysphagia, fatigue,and slurred speech can have a broad differential diagnosis [1].CT scan with iodinated contrast media is often performed toinvestigate symptoms connectedwith this disease (likeweightloss).

2. Case Presentation

In April 2013, a 79-year-old man was admitted to our gen-eral hospital for a 6-week history of progressive dysphagiato solids and liquids associated with weight loss of 3 kg.He denied any other symptoms. His past medical historyincluded type II diabetes, hypertension, and COPD.He couldwalk and neurological examination showed no ocular symp-toms or muscle weakness. There was a mild dehydration, butexamination of the cardiovascular and abdominal systemswas unremarkable. Investigations showed a mild increase ofserum creatinine (1.3mg/dL). Gastroscopy showed a mildhyperemic duodenitis: for this reason a therapy with Panto-prazole was started.

During the stay in our ward he developed a progressiveasthenia, leading to inability to walk and to lift the head to

watch the examiner without using his hand. A blood sam-ple was taken to test for acetylcholine-receptor antibodies.The same day, a total body CT scan with low-osmolalityiodinate contrast agent (Iohexol, concentration 300mgI/mL,volume 200mL) was performed. Two hours later the patientdeveloped an acute respiratory failure requiring orotrachealintubation and mechanical ventilation. In the Intensive CareUnit the weaning of mechanical ventilation was soon ini-tiated and after two days the extubation was performed.After the extubation the patient showed complete dysphagia,dysarthria, hypophonia, and proximal muscle hyposthenia.While waiting for the serologic test, pyridostigmine wasgiven: there was a marked improvement in the following 24hours with a complete neurological recovery. The diagnosisof myasthenia gravis was confirmed by the acetylcholine-receptor antibody test, by the repetitive nerve stimulation,and by the single fibre electromyography.

Before the CT scan, the patient never experienced respi-ratory symptoms (dyspnea or orthopnea) and there were nosigns of a reexacerbation of COPD (no productive cough; thechest examination was negative for rumors, the respiratoryrate was always in the normal range, and the oxygen satura-tion ranged from 94 to 96 in RA). No new drug was added tothe therapy with Pantoprazole (that had been administereddaily for ten days before the acute respiratory event and it is

Hindawi Publishing CorporationCase Reports in RadiologyVolume 2014, Article ID 963461, 2 pageshttp://dx.doi.org/10.1155/2014/963461

2 Case Reports in Radiology

still ongoing). Our diagnosis was a myasthenic crisis inducedby the low-osmolality iodinate contrast agent.

3. Discussion

Many drugs can unmask or exacerbate myasthenia gravis,among them the iodinated contrast agents.There have been afew case reports and case series describing isolated examplesof a myasthenic crisis after exposure to intravenous high-osmolality iodinate material, but, to our knowledge, onlythree other case reports have associated myasthenic crisiswith exposure to low-osmolality contrast media [2, 3].

This suggests being careful in administering low-osmo-lality contrast media in myasthenic patients.

We also think that myasthenic crisis induced by contrastmedia is underrecognised. In our opinion the diagnosis ofmyasthenic crisis should always be considered in the presenceof respiratory symptoms after contrast media to define thereal size of the problem and evaluate the opportunity toperform a noncontrast CT scan or a MRI. If no other optionsare possible, we suggest premedicating myasthenic patientsbefore CT scan with iodinated contrast media.

Conflict of Interests

The authors declare that there is no conflict of interestsregarding the publication of this paper.

References

[1] R. Libman, R. Benson, and K. Einberg, “Myasthenia mimickingvertebrobasilar stroke,” Journal of Neurology, vol. 249, no. 11, pp.1512–1514, 2002.

[2] G. P. Anzola, R. Capra, M. Magoni, and L. A. Vignolo, “Myas-thenic crisis during intravenous iodinated contrast mediuminjection,” Italian Journal of Neurological Sciences, vol. 7, no. 2,p. 273, 1986.

[3] D. K. Somashekar, M. S. Davenport, R. H. Cohan, J. R. Dillman,and J. H. Ellis, “Effect of intravenous low-osmolality iodinatedcontrast media on patients with myasthenia gravis,” Radiology,vol. 267, no. 3, pp. 727–734, 2013.

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com